Observational Study of Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Background: Sickle Cell Disease (SCD) causes blood cells form a crescent shape. It is caused by a genetic mutation in the hemoglobin gene. People with SCD are at increased risk for illnesses like stroke, chronic pain, and heart problems, as well as decreased overall health and well-being. Researchers want to learn more about how nutrition and diet can help relieve or reduce the symptoms of SCD.

Objective: To understand how diet, dietary patterns and behaviors, nutrition, and other related factors in adults with SCD affect their overall health.

Eligibility: Adults aged 18 and older with SCD.

Design: Participants will be screened with a review of their medical records. They will take a pregnancy test if needed. Participants will have a physical exam and medical history. Their height, weight, and waist and hip circumference will be measured. They can complete this exam (1) via telehealth along with a visit to an outpatient laboratory center or (2) by going to the NIH Clinical Center. Participants will complete 2 interviews about their diet. They will talk about the foods they ate in the past 24 hours. They will also complete 1 interview about diet-related behaviors such as food shopping and cooking. They can complete the interviews in person, by phone, or by telehealth visit. Participants will complete surveys about their demographics (such as age and gender), SCD pain, mood, stress, diet, and nutrition. It may take about 1 hour to complete all of the surveys. Participants will give blood and urine samples. They will need to fast for at least 8 hours overnight before giving blood samples. Participation will last for about 2 weeks.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 120
Healthy Volunteers: f
View:

⁃ In order to be eligible to participate in this study, the participant must:

• State their willingness to complete all study procedures for the duration of the study

• 18 years of age or older at the time of screening

• Have a documented clinical diagnosis (upon review of medical records) of SCD or presence of a SCD hemoglobinopathy genotype HbSS, HgSC, HbSB 0 or HBSB+

Locations
United States
Maryland
National Institutes of Health Clinical Center
RECRUITING
Bethesda
Contact Information
Primary
Stephanie L Wildridge, R.N.
wildridgesl@mail.nih.gov
(240) 927-2603
Backup
Nicole M Farmer, M.D.
nicole.farmer@nih.gov
(301) 412-4054
Time Frame
Start Date: 2022-05-26
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 80
Treatments
Patients
outpatient adults with the diagnosis of Sickle Cell Disease
Sponsors
Collaborators: National Human Genome Research Institute (NHGRI), National Heart, Lung, and Blood Institute (NHLBI)
Leads: National Institutes of Health Clinical Center (CC)

This content was sourced from clinicaltrials.gov